Xie, Chenglong
Zhuang, Xu-Xu http://orcid.org/0000-0002-2938-5923
Niu, Zhangming
Ai, Ruixue http://orcid.org/0000-0001-9870-3692
Lautrup, Sofie
Zheng, Shuangjia
Jiang, Yinghui
Han, Ruiyu
Gupta, Tanima Sen
Cao, Shuqin
Lagartos-Donate, Maria Jose
Cai, Cui-Zan
Xie, Li-Ming
Caponio, Domenica http://orcid.org/0000-0002-3827-8943
Wang, Wen-Wen
Schmauck-Medina, Tomas http://orcid.org/0000-0003-4618-0628
Zhang, Jianying
Wang, He-ling http://orcid.org/0000-0002-8920-1487
Lou, Guofeng
Xiao, Xianglu
Zheng, Wenhua
Palikaras, Konstantinos http://orcid.org/0000-0001-6992-5560
Yang, Guang http://orcid.org/0000-0001-7344-7733
Caldwell, Kim A. http://orcid.org/0000-0003-1580-6122
Caldwell, Guy A. http://orcid.org/0000-0002-8283-9090
Shen, Han-Ming
Nilsen, Hilde
Lu, Jia-Hong http://orcid.org/0000-0002-1147-125X
Fang, Evandro F. http://orcid.org/0000-0003-0355-7202
Article History
Received: 20 February 2021
Accepted: 24 September 2021
First Online: 6 January 2022
Competing interests
: E.F.F. and H.N. have a cooperative research and development agreement with ChromaDex. E.F.F., G.Y. and H.N. are consultants to Aladdin Healthcare Technologies. E.F.F. is a consultant to the Vancouver Dementia Prevention Centre and Intellectual Labs. During the execution of this work, S.Z. was a paid part-time employee of MindRank Al Ltd. Z.N., Y.J. and X.X. are full-time employees of MindRank Al Ltd. E.F.F., J.-H.L, Z.N., C.X. and X.-X.Z. have filed a patent on the use of mitophagy inducers to treat Alzheimer’s disease. The other authors declare no competing interests.